Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Delve Bio

Profile checked Oct 10, 2026

Keywords: Central Nervous System Infection

1Trials (company is sponsor)

Timeline

May 1, 2026 Trial start Not phased (device or behavioral study): Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervo source ↗

Upcoming milestones

Jun 1, 2027 (ESTIMATED) · Not phased · Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous Sy · NCT07435649

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07435649	Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) Infection	Not phased (device or behavioral study)	Recruiting	May 1, 2026	Jun 1, 2027 (estimated)